Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 2005Pharmacogenomics

Pharmacogenetics and Nicotine Addiction Treatment

View Full Paper
Ask AI
Bookmark
Share

Authors

Marcus R. MunafòMarcus R. MunafòNorthwestern UniversityASAlexandra E. ShieldsMassachusetts General HospitalWBWade H. BerrettiniUniversity of Pennsylvania

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Munafò et al. (2005) studied this question.

synapsesocial.com/papers/6a1a43d8768e71e76eef233ehttps://doi.org/10.1517/14622416.6.3.211
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Genetic Case-Control Association Studies in Neuropsychiatry2001 · 122 citations
  2. 2The new genetics and primary care: GPs' views on their role and their educational needs1999 · 176 citations
  3. 3Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction1998 · 1,080 citations
  4. 4Sustained-Release Bupropion for Smoking Cessation in African Americans2002 · 244 citations